CELLDEX THERAPEUTICS INC NEW

Ticker: CLDX CUSIP: 15117B202 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 11,632 Value ($000) $301 Avg Close $23.17 Range $19.72 - $26.46

Q3 2024

Shares 86,573 Value ($000) $2,943 Avg Close $38.10 Range $28.51 - $47.00

Q1 2024

Shares 64,769 Value ($000) $2,718 Avg Close $41.06 Range $34.65 - $53.18

Q4 2023

Shares 24,119 Value ($000) $957 Avg Close $29.41 Range $22.11 - $41.47

Q3 2023

Shares 27,415 Value ($000) $754 Avg Close $31.35 Range $24.89 - $38.33

Q1 2022

Shares 61,240 Value ($000) $2,086 Avg Close $31.97 Range $26.47 - $39.84

Q4 2021

Shares 7,362 Value ($000) $284 Avg Close $43.58 Range $35.00 - $57.20

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	11,632	$301	$23.17	$19.72 - $26.46
Q3 2024	86,573	$2,943	$38.10	$28.51 - $47.00
Q1 2024	64,769	$2,718	$41.06	$34.65 - $53.18
Q4 2023	24,119	$957	$29.41	$22.11 - $41.47
Q3 2023	27,415	$754	$31.35	$24.89 - $38.33
Q1 2022	61,240	$2,086	$31.97	$26.47 - $39.84
Q4 2021	7,362	$284	$43.58	$35.00 - $57.20